Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;58(2):374-381.
doi: 10.1002/ppul.26227. Epub 2022 Dec 1.

Pediatric pulmonology 2021 year in review: Rare and diffuse lung disease

Affiliations
Review

Pediatric pulmonology 2021 year in review: Rare and diffuse lung disease

Jonathan Popler et al. Pediatr Pulmonol. 2023 Feb.

Abstract

The field of rare and diffuse pediatric lung disease is experiencing rapid progress as diagnostic and therapeutic options continue to expand. In this annual review, we discuss manuscripts published in Pediatric Pulmonology in 2021 in (1) children's interstitial and diffuse lung disease, (2) congenital airway and lung malformations, and (3) noncystic fibrosis bronchiectasis including primary ciliary dyskinesia. These include case reports, descriptive cohorts, trials of therapies, animal model studies, and review articles. The results are put into the context of other literature in the field. Each furthers the field in important ways, while also highlighting the continued need for further studies.

Keywords: bronchiectasis; congenital abnormalities; interstitial lung disease; primary ciliary dyskinesia.

PubMed Disclaimer

Similar articles

References

REFERENCES

    1. Kurland G, Deterding RR, Hagood JS, et al. An official American thoracic society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 2013;188(3):376-394. doi:10.1164/rccm.201305-0923ST
    1. Fan LL, Dishop MK, Galambos C, et al. Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the chILD classification scheme. Ann Am Thorac Soc. 2015;12(10):1498-1505. doi:10.1513/AnnalsATS.201501-064OC
    1. Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007;176(11):1120-1128. doi:10.1164/rccm.200703-393OC
    1. Deterding R, Griese M, Deutsch G, et al. Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease. ERJ Open Res. 2021;7(2):00805-2020. doi:10.1183/23120541.00805-2020
    1. Kerby GS, Wagner BD, Popler J, et al. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol. 2013;48(10):1008-1015. doi:10.1002/ppul.22718

LinkOut - more resources